Vaccine against hepatitis B — 18 months prevention in a high risk setting
Authors:
- 1 November 1978
- journal article
- Published by Springer Nature in Medical Microbiology and Immunology
- Vol. 166 (1-4) , 109-118
Abstract
The development of a vaccine against hepatitis B prepared with purified and inactivated HBs Ag is described. This vaccine has been applied in patients and staff members of haemodialysis centres. Safety and efficiency of the vaccine are very satisfactory. The response of patients to immunisation was significantly lower compared to the response of the staff members. None of the volunteers who had a primary response to immunisation developed signs of clinical or biological hepatitis.Keywords
This publication has 21 references indexed in Scilit:
- Hepatitis B Vaccine: Efficacy in High-Risk Settings, a Two-Year StudyIntervirology, 1978
- IMMUNISATION AGAINST HEPATITIS B IN MANThe Lancet, 1976
- A case/control study of the association between primary liver cancer and hepatitis b infection in senegalInternational Journal of Cancer, 1975
- Hepatitis B subunit vaccineThe American Journal of the Medical Sciences, 1975
- Purified and inactivated human hepatitis B vaccineThe American Journal of the Medical Sciences, 1975
- Hepatitis B immune serum globulin and standard gamma globulin in prevention of hepatitis B infection among hospital staffThe American Journal of the Medical Sciences, 1975
- Attempt to prevent hepatitis by using specific anti-HBs immunoglobulinThe American Journal of the Medical Sciences, 1975
- The Purification of Hepatitis‐Associated Antigen (HAA/SH/AU) from Human Serum and the Preparation of a Sheep Anti‐HAA SerumVox Sanguinis, 1972
- Chemical Coupling of Peptides and Proteins to Polysaccharides by Means of Cyanogen HalidesNature, 1967
- The fractionation of protein mixtures by linear polymers of high molecular weightBiochimica et Biophysica Acta (BBA) - General Subjects, 1964